Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)

Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)

Abstract Background Preoperative imatinib mesylate (IM) treatment has not yet been standardized. Here, we aim to further explore such therapy on patients with gastrointestinal stromal tumors (GIST) retrospectively. Methods Patients experiencing preoperative IM were identified from January 2009 to Fe...

Full description

Bibliographic Details
Main Authors: Sumin Tang, Yuan Yin, Chaoyong Shen, Jiaju Chen, Xiaonan Yin, Bo Zhang, Yuqin Yao, Jinliang Yang, Zhixin Chen
Format: Article
Language:English
Published: BMC 2017-04-01
Series:World Journal of Surgical Oncology
Subjects:
Gastrointestinal stromal tumors
Preoperative imatinib mesylate
Progression-free survival
Overall survival
Online Access:http://link.springer.com/article/10.1186/s12957-017-1143-2

Internet

http://link.springer.com/article/10.1186/s12957-017-1143-2

Similar Items